Evidence map›Paper›PMID 35684441›Full record

ArticleMolecules (Basel, Switzerland)2022

Casiopeinas of Third Generations: Synthesis, Characterization, Cytotoxic Activity and Structure-Activity Relationships of Mixed Chelate Compounds with Bioactive Secondary Ligands.

Yeshenia Figueroa-DePaz, Jaime Pérez-Villanueva, Olivia Soria-Arteche, Diego Martínez-Otero, Virginia Gómez-Vidales, Luis Ortiz-Frade, Lena Ruiz-Azuara

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Synthesis of (1,10-Phenanthroline-Molecules (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yeshenia Figueroa-DePazDepartamento de Química Inorgánica y Nuclear, Facultad de Química, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City 04510, Mexico.
Jaime Pérez-VillanuevaDepartamento de Sistemas Biológicos, División de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropollitana-Xochimilco (UAM-X), Mexico City 04960, Mexico.ORCID 0000-0001-5777-2536
Olivia Soria-ArtecheDepartamento de Sistemas Biológicos, División de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropollitana-Xochimilco (UAM-X), Mexico City 04960, Mexico.
Diego Martínez-OteroCentro Conjunto de Investigación en Química Sustentable UAEM-UNAM, Carretera Toluca-Atlacomulco, Km.14.5, Toluca 50200, Mexico.
Virginia Gómez-VidalesInstituto de Química, Universidad Nacional Autónoma de México, Av. Universidad 3000, C.U., Mexico City 04510, Mexico.
Luis Ortiz-FradeCentro de Investigación y Desarrollo Tecnológico en Electroquímica S.C. Parque Tecnológico Querétaro, Sanfandila, Pedro de Escobedo, Querétaro 76703, Mexico.ORCID 0000-0001-6523-8018
Lena Ruiz-AzuaraDepartamento de Química Inorgánica y Nuclear, Facultad de Química, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City 04510, Mexico.ORCID 0000-0003-3035-4507

Funding

CONACYT 589195LANCAD-UNAM-DGTIC 358UNAM-PAIP 5000-9047UNAM-PAPIIT IN230020
6 · The paper itself

Abstract

Casiopeinas are a family of copper(II) coordination compounds that have shown an important antineoplastic effect and low toxicity in normal cells. These compounds induce death cells by apoptosis through a catalytic redox process with endogenous reducing agents. Further studies included a structural variation, improving the activity and selectivity in cancer cells or other targets. In the present work we report the third generation, which contains a bioactive monocharged secondary ligand, as well as the design, synthesis, characterization and antiproliferative activity, of sixteen new copper(II) coordination compounds with curcumin or dimethoxycurcumin as secondary ligands. All compounds were characterized by elemental analysis, FTIR, UV-Vis, magnetic susceptibility, mass spectra with MALDI-flight time, cyclic voltammetry, electron paramagnetic resonance (EPR) spectroscopy and X-ray diffraction. Crystallization of two complexes was achieved in dimethylsulfoxide (DMSO) with polar solvent, and crystal data demonstrated that a square-based or square-base pyramid geometry are possible. A 1:1:1 stoichiometry (diimine: copper: curcuminoid) ratio and the possibility of a nitrate ion as a counterion were supported.

Indexed as

Antineoplastic AgentsCoordination ComplexesCell Line, TumorCopperCrystallography, X-RayHumansLigandsStructure-Activity RelationshipAntineoplastic AgentsCoordination ComplexesCopperLigandsCasiopeinascoppercurcumincytotoxic activityDFTdimethoxycurcuminmetallodrugsredox potential

Identifiers

PMID35684441
PMCPMC9182210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.